Cita APA

Jones, R. N., Moeck, G., Arhin, F. F., Dudley, M. N., Rhomberg, P. R., & Mendes, R. E. (2016). Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility. Antimicrob Agents Chemother.

Chicago Style Citation

Jones, Ronald N., Greg Moeck, Francis F. Arhin, Michael N. Dudley, Paul R. Rhomberg, i Rodrigo E. Mendes. "Results From Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin As a Surrogate To Infer Oritavancin Susceptibility." Antimicrob Agents Chemother 2016.

Cita MLA

Jones, Ronald N., et al. "Results From Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin As a Surrogate To Infer Oritavancin Susceptibility." Antimicrob Agents Chemother 2016.